Novo Nordisk A/S
NVO
ISIN null / Valor 461641
Novo Nordisk A/S
UMushroom community rating:
About company
Novo Nordisk A/S is a Danish multinational pharmaceutical company focused principally on diabetes care and related metabolic disorders, developing, manufacturing and commercializing medicines and delivery devices—most prominently insulin and GLP‑1 receptor agonists used in type 2 diabetes and obesity treatment—and it also markets therapies for haemophilia, growth disorders and hormone replacement. The company combines clinical research and development with large‑scale manufacturing and worldwide commercial operations and is publicly listed on the Copenhagen stock exchange. Internally, Novo Nordisk operates under corporate conduct frameworks (OneCode and the Novo Nordisk Way) that define expected standards of behaviour and decision‑making for employees.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
122400 M
Market cap (USD)
16,442,749
Daily traded volume (Shares)
86.86 / 85.69
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Fabio Kull
Paulina María Herrera Ovalle
Robin Saint-Ghislain
EQUITIES OF THE SAME SECTOR
